Published in Healthcare Mergers, Acquisitions and Ventures Week, May 19th, 2007
Interfering substances such as heparin, lipids, bilirubin, and haemolyzed plasma are commonly found in patient samples. At minimal levels, these substances do not obstruct assay results. However, when levels...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.